Ahmad Hassan Ali
Overview
Explore the profile of Ahmad Hassan Ali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramanathan R, Patwa S, Ali A, Ibdah J
Cells
. 2023 Dec;
12(24).
PMID: 38132126
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly termed nonalcoholic fatty liver disease (NAFLD), is a widespread global health concern that affects around 25% of the global population. Its influence is...
2.
Ramanathan R, Ali A, Ibdah J
Int J Mol Sci
. 2022 Jul;
23(13).
PMID: 35806284
Nonalcoholic fatty liver disease (NAFLD) is a global pandemic that affects one-quarter of the world's population. NAFLD includes a spectrum of progressive liver disease from steatosis to nonalcoholic steatohepatitis (NASH),...
3.
Ali A, Al Juboori A, Petroski G, Diaz-Arias A, Syed-Abdul M, Wheeler A, et al.
J Clin Med
. 2022 Mar;
11(5).
PMID: 35268293
Patients with morbid obesity are at high risk for nonalcoholic fatty liver disease (NAFLD) complicated by liver fibrosis. The clinical utility of transient elastography (TE) by Fibroscan in patients with...
4.
Ali A, Juran B, Schlicht E, Bianchi J, McCauley B, Atkinson E, et al.
BMC Gastroenterol
. 2021 Sep;
21(1):353.
PMID: 34563121
Background: Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease that often progresses to end-stage liver disease and/or the development of hepatobiliary neoplasia. Lack of prognostic tools and...
5.
Ali A, Petroski G, Diaz-Arias A, Al Juboori A, Wheeler A, Ganga R, et al.
J Clin Med
. 2021 Aug;
10(15).
PMID: 34362095
We assessed the relationship between serum alkaline phosphatase (ALP) and liver fibrosis by histology, in addition to other noninvasive parameters, in obese patients undergoing metabolic surgery. Patients scheduled for elective...
6.
Buness C, Johnson K, Ali A, Alrabadi L, Lindor K, Miloh T, et al.
Clin J Gastroenterol
. 2020 Nov;
14(2):684-689.
PMID: 33231850
Primary sclerosing cholangitis (PSC) is a rare, progressive liver disease characterized by cholestasis and bile duct fibrosis that has no accepted therapy known to delay or arrest its progression. We...
7.
Ali A, Bi Y, Machicado J, Garg S, Lennon R, Zhang L, et al.
J Gastroenterol
. 2020 Aug;
55(11):1087-1097.
PMID: 32770464
Background: The long-term outcomes of immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) are not well known. Methods: The outcomes of patients with IgG4-SC at Mayo Clinic (1999-2018) were compared to an age-...
8.
Ali A, Damman J, Shah S, Davies Y, Hurwitz M, Stephen M, et al.
Scand J Gastroenterol
. 2020 Jul;
55(8):941-950.
PMID: 32633158
Background: Oral vancomycin (OV) in primary sclerosing cholangitis (PSC) has been evaluated as a potential therapeutic agent. We report the long-term biochemical course and outcomes of patients with PSC treated...
9.
Ali A, Panchal S, Rao D, Gan Y, Al-Juboori A, Samiullah S, et al.
J Ultrasound
. 2020 Mar;
23(2):157-167.
PMID: 32141043
Background And Aims: There is limited literature on endoscopic ultrasound-guided liver biopsy (EUS-LB), a new method of obtaining liver biopsy (LB). Methods: We conducted a retrospective study of the efficacy...
10.
Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series
Buness J, Ali A, Tabibian J, Buness C, Cox K, Lindor K
Am J Ther
. 2019 Oct;
29(4):e437-e443.
PMID: 31567143
Background: Primary sclerosing cholangitis (PSC) is linked to inflammatory bowel diseases (IBD). Evidence suggests an association between the gut microbiome and PSC. However, the putative relationship between exposure to antibiotics...